Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance
Twist Bioscience (NASDAQ: TWST) has achieved LEED certification for its Wilsonville, OR facility, demonstrating its commitment to sustainability in operations and maintenance. The certification, awarded by the U.S. Green Building Council, recognizes the facility's adherence to LEED v4.1 Operations + Maintenance standards.
CEO Emily M. Leproust emphasized that this achievement aligns with Twist's mission to improve health and sustainability. The company previously quantified the carbon footprint of gene production using their platform, showing significant environmental benefits compared to traditional methods. This LEED certification further solidifies Twist's commitment to providing customers with DNA produced in a sustainable facility using fewer chemical reagents.
Twist Bioscience (NASDAQ: TWST) ha ottenuto la certificazione LEED per il suo stabilimento di Wilsonville, OR, dimostrando il suo impegno per la sostenibilità nelle operazioni e nella manutenzione. La certificazione, concessa dal U.S. Green Building Council, riconosce l'aderenza dell'impianto agli standard LEED v4.1 per Operazioni + Manutenzione.
Il CEO Emily M. Leproust ha enfatizzato che questo risultato è in linea con la missione di Twist di migliorare la salute e la sostenibilità. L'azienda ha in precedenza quantificato l'impronta di carbonio della produzione di geni utilizzando la propria piattaforma, mostrando benefici ambientali significativi rispetto ai metodi tradizionali. Questa certificazione LEED rafforza ulteriormente l'impegno di Twist nel fornire ai clienti DNA prodotto in un impianto sostenibile utilizzando meno reagenti chimici.
Twist Bioscience (NASDAQ: TWST) ha logrado la certificación LEED para su instalación en Wilsonville, OR, demostrando su compromiso con la sostenibilidad en las operaciones y el mantenimiento. La certificación, otorgada por el U.S. Green Building Council, reconoce la adherencia de la instalación a los estándares LEED v4.1 para Operaciones + Mantenimiento.
La CEO Emily M. Leproust enfatizó que este logro está alineado con la misión de Twist de mejorar la salud y la sostenibilidad. La compañía ya había cuantificado la huella de carbono de la producción de genes utilizando su plataforma, mostrando beneficios ambientales significativos en comparación con los métodos tradicionales. Esta certificación LEED refuerza aún más el compromiso de Twist de proporcionar a los clientes ADN producido en una instalación sostenible utilizando menos reactivos químicos.
트위스트 바이오사이언스(Twist Bioscience, NASDAQ: TWST)는 오레곤 주 윌슨빌에 있는 시설에 대해 LEED 인증을 달성하여 운영 및 유지 관리에서 지속 가능성에 대한 헌신을 입증했습니다. 미국 녹색 건축 위원회(U.S. Green Building Council)에서 수여한 이 인증은 해당 시설이 LEED v4.1 운영 + 유지 관리 기준을 준수하고 있음을 인정합니다.
CEO 에밀리 M. 레프루스트(Emily M. Leproust)는 이 성과가 건강과 지속 가능성을 개선하려는 트위스트의 사명과 일치한다고 강조했습니다. 이 회사는 이전에 자신의 플랫폼을 사용하여 유전자 생산의 탄소 발자국을 정량화하여 전통적인 방법에 비해 상당한 환경적 이점을 보여주었습니다. 이 LEED 인증은 더 적은 화학 시약을 사용하여 지속 가능한 시설에서 DNA를 고객에게 제공하겠다는 트위스트의 헌신을 더욱 확고히 합니다.
Twist Bioscience (NASDAQ: TWST) a obtenu la certification LEED pour son établissement à Wilsonville, OR, démontrant ainsi son engagement en faveur de la durabilité dans ses opérations et sa maintenance. Cette certification, attribuée par le U.S. Green Building Council, reconnaît la conformité de l'établissement aux normes LEED v4.1 pour les opérations et la maintenance.
La PDG Emily M. Leproust a souligné que cette réalisation s'inscrit dans la mission de Twist d'améliorer la santé et la durabilité. L'entreprise avait auparavant quantifié l'empreinte carbone de la production de gènes utilisant sa plateforme, montrant des avantages environnementaux significatifs par rapport aux méthodes traditionnelles. Cette certification LEED renforce encore l'engagement de Twist à fournir à ses clients de l'ADN produit dans une installation durable utilisant moins de réactifs chimiques.
Twist Bioscience (NASDAQ: TWST) hat die LEED-Zertifizierung für seine Einrichtung in Wilsonville, OR, erreicht, was sein Engagement für Nachhaltigkeit in Betrieb und Wartung zeigt. Die Zertifizierung, die vom U.S. Green Building Council vergeben wurde, erkennt die Einhaltung der LEED v4.1 Betriebs- + Wartungsstandards durch die Einrichtung an.
CEO Emily M. Leproust betonte, dass dieser Erfolg mit der Mission von Twist übereinstimmt, Gesundheit und Nachhaltigkeit zu verbessern. Das Unternehmen hat zuvor den CO2-Fußabdruck der Genproduktion mithilfe seiner Plattform quantifiziert und dabei erhebliche Umweltvorteile im Vergleich zu traditionellen Methoden aufgezeigt. Diese LEED-Zertifizierung untermauert das Engagement von Twist, den Kunden DNA in einer nachhaltigen Einrichtung mit weniger chemischen Reagenzien zur Verfügung zu stellen.
- Achieved LEED certification for Wilsonville, OR facility
- Demonstrates commitment to sustainability in operations and maintenance
- Significantly lower carbon footprint for gene production compared to traditional methods
- None.
Twist Bioscience's LEED certification for its Wilsonville facility marks a significant step in sustainable biotechnology operations. This achievement aligns with the company's mission of improving health and sustainability, demonstrating a commitment beyond just product offerings. The certification covers important areas like energy efficiency, water conservation and indoor environmental quality, potentially leading to cost savings and improved operational efficiency.
Notably, Twist's gene synthesis process reportedly has a drastically lower carbon footprint compared to traditional methods - equivalent to 0.092 miles of driving versus 59 miles for conventional 96-well plate approaches. This
While this certification is a positive step, investors should consider its tangible impact on Twist's bottom line and market perception. The real test will be in how Twist leverages this achievement to attract environmentally conscious customers and potentially command premium pricing for its sustainably produced DNA products.
Twist Bioscience's LEED certification for its Wilsonville facility is a noteworthy development in the competitive synthetic biology landscape. This achievement could potentially differentiate Twist from competitors by appealing to environmentally conscious clients in academia and industry. However, the direct impact on Twist's financial performance remains to be seen.
The company's claim of significantly reduced carbon footprint in gene synthesis is particularly intriguing. If validated, this could be a major selling point, especially as more organizations prioritize sustainable supply chains. However, investors should be cautious about overstating the immediate financial implications. While sustainability is increasingly important, it's often not the primary factor in purchasing decisions for highly specialized biotech products.
Looking ahead, Twist should focus on quantifying the tangible benefits of this certification, such as potential cost savings from improved energy efficiency or increased customer acquisition due to sustainability credentials. These metrics will be important for investors to assess the true value of this achievement.
“We founded Twist to improve health and sustainability, and every day we work toward that mission by providing our customers with products to enable them to build a better world,” said Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience. “Last year we quantified the carbon footprint of making a gene using the Twist platform and found that our approach is the equivalent of driving 0.092 miles (0.15km) compared to 59 miles (95km) using a 96-well plate approach1. By achieving LEED certification for our
LEED (Leadership in Energy and Environmental Design) is a globally recognized green building rating system that provides a framework for healthy, highly efficient, and cost-saving green buildings. The LEED v4.1 Operations + Maintenance (O+M) certification applies to existing buildings that are undergoing improvement work or little to no construction. Certified buildings meet requirements for location and transportation; sustainable sites; water efficiency; energy and atmosphere; materials and resources; indoor environmental quality; and innovation.
To order Twist products, click here. To learn more about corporate responsibility efforts at Twist, click here.
1Calculated Twist internal data using Dr. Oligo benchmark January 2021. Comparison calculated using the EPA Greenhouse Gas Equivalencies Calculator.
About Twist Bioscience Corporation
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.
Follow us on LinkedIn | X | YouTube | Instagram
View source version on businesswire.com: https://www.businesswire.com/news/home/20240911243702/en/
For Investors:
Angela Bitting
SVP, Corporate Affairs
925-202-6211
abitting@twistbioscience.com
For Media:
Amanda Houlihan
Communications Manager
774-265-5334
ahoulihan@twistbioscience.com
Source: Twist Bioscience Corporation
FAQ
What certification did Twist Bioscience (TWST) receive for its Wilsonville facility?
How does Twist Bioscience's (TWST) gene production compare to traditional methods in terms of carbon footprint?
What is the significance of LEED certification for Twist Bioscience (TWST)?
How does the LEED certification of Twist Bioscience (TWST) benefit its customers?
